ENTITY
Jcr Pharmaceuticals

Jcr Pharmaceuticals (4552 JP)

23
Analysis
Health CareJapan
JCR Pharmaceuticals Co., Ltd. develops, produces, and sells pharmaceutical products and raw materials. The Company also sells equipment for hospital and laboratory use. JCR Pharmaceuticals' products include drug for leukemic diseases and hormonal agents including genetically engineered human somatotrophic hormone (growth hormone) and gonadotropic hormone.
more
30 Oct 2024 20:58

JCR Pharma (4552) - Uglyish In-Line Results But a Buyback Opportunity for Someone

Contract pharmaceutical smallcap sponsored by Medipal and crossholders JCR Pharma produces ugly H1 results, but they appear "in-line." Guidance is...

Logo
248 Views
Share
03 Nov 2024 07:30

APAC Healthcare Weekly (Nov 3)- Eisai, Takeda, Shionogi, Astellas Pharma, Celltrion, Wuxi AppTec

Large APAC healthcare companies are reporting mixed earnings. Demography will play a key role in ensuring how the overall domestic demand scenario...

Logo
454 Views
Share
bullishDenso Corp
03 Nov 2024 07:00

Last Week in Event SPACE: Denso/Toyota, Korea Zinc, Exedy, Good Drinks, Shinsegae

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

Logo
323 Views
Share
27 Oct 2024 07:30

APAC Healthcare Weekly (Oct 27)- Samsung Biologics, Celltrion, Astellas, Otsuka, Legend, and Zai Lab

Samsung Biologics secures largest ever contract, Celltrion announced KRW100B buyback, Astellas Pharma got label expansion approval for Vyloy,...

Logo
464 Views
Share
bearishNippon Shinyaku
12 Jun 2023 23:06

Nippon Shinyaku (4516 JP): FY24 Guidance Falls Short of Mid-Term Target; DMD Drug Growth Slows Down

Nippon Shinyaku’s FY24 revenue, operating and net profits guidance are 3%, 20%, and 17% below mid-term target, respectively. Viltepso revenue...

Logo
291 Views
Share
x